KIFC1 Is Associated with Basal Type, Cisplatin Resistance, PD-L1 Expression and Poor Prognosis in Bladder Cancer | Zendy

AI Assistant Blog Pricing

Open Access

KIFC1 Is Associated with Basal Type, Cisplatin Resistance, PD-L1 Expression and Poor Prognosis in Bladder Cancer

Author(s) -

Yohei Sekino

Publication year - 2021

Publication title -

zenodo (cern european organization for nuclear research)

Language(s) - English

DOI - 10.5281/zenodo.5571177

Subject(s) - cisplatin , bladder cancer , oncology , basal (medicine) , medicine , cancer research , cancer , chemotherapy , insulin

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.